Phase 2 Homologous Recombination Deficiency Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Bipolar Androgen Therapy + Carboplatin in mCRPC
Homologous Recombination DeficiencyCastration-resistant Prostate Cancer
St Vincent's Hospital, Sydney30 enrolled1 locationNCT03522064
Recruiting
Phase 2Phase 3
Cisplatin to Patients With Pancreatic Cancer and Homologous Recombination Deficiency
Pancreatic AdenocarcinomaHomologous Recombination Deficiency
Fudan University30 enrolled1 locationNCT06095141
Recruiting
Phase 2
Olaparib in Patients With HRD Malignant Mesothelioma
Homologous Recombination DeficiencyMesothelioma
University of Chicago56 enrolled1 locationNCT04515836
Recruiting
Phase 1Phase 2
A Trial of AMXI-5001 for Treatment in Patients With Advanced Malignancies
Breast CancerPancreatic CancerOvarian Cancer+3 more
AtlasMedx, Incorporated122 enrolled4 locationsNCT04503265
Recruiting
Phase 1Phase 2
EIS-12656 as Single Agent and in Combination in Patients With Specified Solid Tumors
Advanced Solid TumorHRR DeficiencyHomologous Recombination Deficiency
Eisbach Bio GmbH144 enrolled1 locationNCT06525298